On August 12, 2021, leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Effector Cell-related Adverse Events." This high-level webinar covered advanced concepts of toxicity management and risk factors drawing from recommendations within the Clinical Practice Guideline (CPG). The recorded webinar and presentation slides are available below.
The webinar discussed management and grading of toxicities associated with CAR T therapies and their risk factors, including:
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.
This webinar is supported, in part, by independent medical education grant funding from Amgen and Merck & Co., Inc.The SITC Clinical Practice Guidelines are produced by SITC and have no funding from outside sources.
Meeting: SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Effector Cell-related Adverse Events; Faculty: Jorg Dietrich, MD, PhD – Massachusetts General Hospital; Stephan Grupp, MD, PhD – Children’s Hospital of Philadelphia and University of Pennsylvania; Saatva S. Neelapu, MD – The University of Texas MD Anderson Cancer Center; Date: August 12, 202100:58:57
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com